期刊文献+

痰标本中肺炎克雷伯菌超广谱β-内酰胺酶基因的检测及耐药分析 被引量:1

Study of Klebsiella pneumonia isolated from the sputum on the gene typing of extended-spectrum β-lactamases and antibiotic resistance
下载PDF
导出
摘要 目的分析痰标本中肺炎克雷伯菌的耐药特点及超广谱β-内酰胺酶(ESBLs)的发生率、基因分型。方法收集安徽省内34家医院痰标本中分离到的114株肺炎克雷伯菌,用琼脂稀释法检测其耐药性,标准纸片扩散法及PCR法检测ESBLs基因并初步分型。结果114株肺炎克雷菌中产ESBLs58株(50.9%),其中CTX-M-1型12株,CTX-M-9型15株,TEM型42株,SHV型49株,OXA-1型2株;产ES-BLs肺炎克雷伯菌的耐药率明显高于非产ESBLs菌株。结论痰标本中产ESBLs肺炎克雷伯菌检出率高,且呈多重耐药。 Objective To investigate the antibiotic resistance and genotype distribution of extended-spectrum β- lactamases(ESBLs) producing Klebsiella pneumonia isolated from the sputum. Methods A total of 114 strains of Klebsiella pneumonia were chosed from 34 different hospitals in Anhui province. Agar dilution test was used in susceptibility testing. The ESBLs producers were detected by standard disk diffusion test. In the further test, initial typing of ESBLs was conducted by PCR. Results 58 strains of Klebsiella pneumonia producing ESBLs were deteced ,including CTX-M-1 ( 12 strains ), CTX-M-9 ( 15 strains ), TEM (42 strains ), SHV (49 strains ), OXA-1 (2 strains). The resistant rates of strains producing ESBLs were much higher than that of non-ESBLs-producing strains. Conclusion The Klebsiella pneumonia producing ESBLs isolated from the sputum are common, and most of them are mutiple drug resistant.
出处 《安徽医科大学学报》 CAS 北大核心 2007年第4期398-400,共3页 Acta Universitatis Medicinalis Anhui
关键词 痰/微生物学 抗药性 细菌 克雷伯菌 肺炎/药物作用 Β内酰胺酶类 sputum/microbiology drug resistance, bacterial Klebsiella pneumoniae/drug effects beta-lactamases
  • 相关文献

参考文献5

二级参考文献28

  • 1中华人民共和国卫生部医政司.全国临床检验操作规程(第2 版)[M].南京:东南大学出版社,1997.452-71.
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement M100~S9. Wayne:NCCLS, 1999:32~75.
  • 3Nordmann P.Trends in beta-lactamases resistance among enterobacteriaceae[J].Clin Infect Dis,1998,(Suppl 1):S100-106.
  • 4Jacoby G A. Epidemiology of extended-spectrum β-lactamases[J].Clinic Infect Dis,1998,27(1):81-83.
  • 5Aroonwadee C, Fatima HM,John H,et al.three Cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People,s Republic of China[J].Antimicrobial Agents and Chemotherapy,2002,46(3):630-637.
  • 6Yu WL, Winokur PL, Von Stein DL, et al.First description of Klebiella pneumoniae harboring CTX-M beta-lactamases(CTX-M-14 and CTX-M-3)in Taiwan[J]. Antimicrobial Agents and Chemotherapy,2002,46(4):1098-1100.
  • 7Bradford PA. Extended- spectrum β-lactamases in the 21 st century :characterization,epidemiolgy, and detection of this important resistance threat[J].Clin Microbiol Rev,2001,14(4):933-951.
  • 8Kim Y, Pai H, Lee H, et al.Bloodstream infections by extended-spectrum beta-lactamase-producing E. coli and Klebsiella pneumoniae in chidren: epidemiology and clinical outcome[J]. Antimicrobial Agents and Chemotherapy,2002,46(5):1481-1491.
  • 9Kim J, Kwon Y, Pai JW, et al.Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamase: prevalence of SHV-12 and SHV-2a in Korea[J].J Clin Microbiol, 1998,36(5): 1446-1449.
  • 10Nuesch-Inderbinen MT, Kayser FH, Hachler H. Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes,SHV-11 and SHV-12[J].Antimicro Agents Chemother,1997,41(5):943-949.

共引文献502

同被引文献8

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部